86 related articles for article (PubMed ID: 8090901)
1. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy.
Holland JM; Swift PS
Radiology; 1994 Oct; 193(1):251-4. PubMed ID: 8090901
[TBL] [Abstract][Full Text] [Related]
2. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?
Fraunholz I; Rabeneck D; Gerstein J; Jäck K; Haberl A; Weiss C; Rödel C
Radiother Oncol; 2011 Jan; 98(1):99-104. PubMed ID: 21168927
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and toxicity of chemoradiation in the treatment of HIV-associated anal cancer.
Hauerstock D; Ennis RD; Grossbard M; Evans A
Clin Colorectal Cancer; 2010 Oct; 9(4):238-42. PubMed ID: 20920996
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
[TBL] [Abstract][Full Text] [Related]
6. Management of anal cancer in the HIV-positive population.
Kauh J; Koshy M; Gunthel C; Joyner MM; Landry J; Thomas CR
Oncology (Williston Park); 2005 Nov; 19(12):1634-8; discussion 1638-40, 1645 passim. PubMed ID: 16396154
[TBL] [Abstract][Full Text] [Related]
7. Cancer of the anal canal: treatment with chemotherapy and low-dose radiation therapy.
Smith DE; Shah KH; Rao AR; Frost DB; Latino F; Anderson PJ; Peddada AV; Kagan AR
Radiology; 1994 May; 191(2):569-72. PubMed ID: 8153343
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
[TBL] [Abstract][Full Text] [Related]
9. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.
Roohipour R; Patil S; Goodman KA; Minsky BD; Wong WD; Guillem JG; Paty PB; Weiser MR; Neuman HB; Shia J; Schrag D; Temple LK
Dis Colon Rectum; 2008 Feb; 51(2):147-53. PubMed ID: 18180997
[TBL] [Abstract][Full Text] [Related]
10. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
Edelman S; Johnstone PA
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522
[TBL] [Abstract][Full Text] [Related]
11. [A case of squamous cell carcinoma of the anal cancer with associated human immunodeficiency virus].
Sueda K; Ikenaga M; Miyazaki M; Yasui M; Mishima H; Tsujie M; Omiya H; Miyamoto A; Hirao M; Takami K; Fujitani K; Nakamori S; Yoshida K; Tsujinaka T
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2656-8. PubMed ID: 21224670
[TBL] [Abstract][Full Text] [Related]
12. [Management of anal canal carcinoma].
Thang NN; Cochet S; George AC; Betz M; Roth A
Rev Med Suisse; 2011 May; 7(296):1144-8. PubMed ID: 21721205
[TBL] [Abstract][Full Text] [Related]
13. Squamous-cell carcinoma of the anus in HIV-positive patients.
Chadha M; Rosenblatt EA; Malamud S; Pisch J; Berson A
Dis Colon Rectum; 1994 Sep; 37(9):861-5. PubMed ID: 8076484
[TBL] [Abstract][Full Text] [Related]
14. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
[TBL] [Abstract][Full Text] [Related]
15. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.
Blazy A; Hennequin C; Gornet JM; Furco A; Gérard L; Lémann M; Maylin C
Dis Colon Rectum; 2005 Jun; 48(6):1176-81. PubMed ID: 15906137
[TBL] [Abstract][Full Text] [Related]
16. Anal cancer and its precursors in HIV-positive patients: perspectives and management.
Berry JM; Palefsky JM; Welton ML
Surg Oncol Clin N Am; 2004 Apr; 13(2):355-73. PubMed ID: 15137962
[TBL] [Abstract][Full Text] [Related]
17. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
[TBL] [Abstract][Full Text] [Related]
19. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
[TBL] [Abstract][Full Text] [Related]
20. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]